The Growing Role of Early Disease Identification in the New-Born Screening Market
The New-Born Screening Market is experiencing unprecedented demand, fueled by a combination of technological advancements, legislative support, and heightened awareness of congenital disorders. With projections indicating growth from USD 0.58 billion in 2024 to USD 1.248 billion by 2035, the compound annual growth rate is estimated at 7.21%. This surge reflects a fundamental shift in healthcare...
0 Comments 0 Shares 45 Views 0 Reviews